Manulife (Manufacturers Life Insurance)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.8M | Buy |
101,580
+1,860
| +2% | +$528K | 0.02% | 538 |
|
|
2026
Q1 | $27.8M | Sell |
99,720
-22,854
| -19% | -$6.58M | 0.02% | 519 |
|
|
2025
Q4 | $37.1M | Buy |
122,574
+15,275
| +14% | +$4.77M | 0.03% | 468 |
|
|
2025
Q3 | $30.1M | Sell |
107,299
-12,161
| -10% | -$3.31M | 0.02% | 524 |
|
|
2025
Q2 | $28.8M | Buy |
119,460
+5,458
| +5% | +$1.29M | 0.03% | 517 |
|
|
2025
Q1 | $27.8M | Buy |
114,002
+6,807
| +6% | +$2.05M | 0.03% | 514 |
|
|
2024
Q4 | $35.2M | Buy |
107,195
+20,413
| +24% | +$6.93M | 0.03% | 460 |
|
|
2024
Q3 | $29M | Buy |
86,782
+24,052
| +38% | +$7.64M | 0.03% | 517 |
|
|
2024
Q2 | $17.1M | Sell |
62,730
-16,734
| -21% | -$4.87M | 0.02% | 655 |
|
|
2024
Q1 | $27.5M | Buy |
79,464
+5,854
| +8% | +$1.93M | 0.03% | 529 |
|
|
2023
Q4 | $23.8M | Buy |
73,610
+55,369
| +304% | +$17.4M | 0.01% | 575 |
|
|
2023
Q3 | $6.54M | Buy |
18,241
+2,575
| +16% | +$994K | ﹤0.01% | 993 |
|
|
2023
Q2 | $5.94M | Sell |
15,666
-378
| -2% | -$154K | ﹤0.01% | 997 |
|
|
2023
Q1 | $7.69M | Sell |
16,044
-295
| -2% | -$138K | ﹤0.01% | 901 |
|
|
2022
Q4 | $6.87M | Buy |
16,339
+266
| +2% | +$107K | ﹤0.01% | 921 |
|
|
2022
Q3 | $6.7M | Sell |
16,073
-1,119
| -7% | -$558K | ﹤0.01% | 923 |
|
|
2022
Q2 | $8.51M | Buy |
17,192
+1,405
| +9% | +$732K | 0.01% | 880 |
|
|
2022
Q1 | $8.89M | Sell |
15,787
-3,386
| -18% | -$2.04M | 0.01% | 950 |
|
|
2021
Q4 | $14.5K | Sell |
19,173
-1,643
| -8% | -$1.23M | 0.01% | 783 |
|
|
2021
Q3 | $15.5M | Sell |
20,816
-647
| -3% | -$485K | 0.01% | 754 |
|
|
2021
Q2 | $13.8M | Buy |
21,463
+1,044
| +5% | +$635K | 0.01% | 819 |
|
|
2021
Q1 | $11.7M | Sell |
20,419
-1,568
| -7% | -$929K | 0.01% | 884 |
|
|
2020
Q4 | $12.8M | Sell |
21,987
-562
| -2% | -$320K | 0.01% | 793 |
|
|
2020
Q3 | $11.6M | Sell |
22,549
-9,753
| -30% | -$4.94M | 0.01% | 736 |
|
|
2020
Q2 | $14M | Sell |
32,302
-15,915
| -33% | -$7.02M | 0.01% | 649 |
|
|
2020
Q1 | $16.9M | Buy |
48,217
+11,959
| +33% | +$4.4M | 0.02% | 539 |
|
|
2019
Q4 | $13.4M | Sell |
36,258
-119,117
| -77% | -$42M | 0.01% | 691 |
|
|
2019
Q3 | $51.9M | Sell |
155,375
-9,806
| -6% | -$3.2M | 0.06% | 303 |
|
|
2019
Q2 | $51.6M | Buy |
165,181
+29,688
| +22% | +$8.89M | 0.06% | 296 |
|
|
2019
Q1 | $41.4M | Sell |
135,493
-88,634
| -40% | -$23.9M | 0.04% | 354 |
|
|
2018
Q4 | $52M | Buy |
224,127
+43,538
| +24% | +$11.7M | 0.07% | 279 |
|
|
2018
Q3 | $56.5M | Sell |
180,589
-26,161
| -13% | -$8.12M | 0.06% | 297 |
|
|
2018
Q2 | $59.7M | Sell |
206,750
-17,755
| -8% | -$4.9M | 0.07% | 294 |
|
|
2018
Q1 | $56.1M | Buy |
224,505
+11,627
| +5% | +$2.96M | 0.06% | 300 |
|
|
2017
Q4 | $50.8M | Sell |
212,878
-33,070
| -13% | -$8.01M | 0.05% | 335 |
|
|
2017
Q3 | $54.7M | Buy |
245,948
+15,856
| +7% | +$3.57M | 0.07% | 291 |
|
|
2017
Q2 | $52.1M | Sell |
230,092
-74,805
| -25% | -$16.3M | 0.06% | 307 |
|
|
2017
Q1 | $60.8M | Buy |
304,897
+10,143
| +3% | +$1.95M | 0.08% | 264 |
|
|
2016
Q4 | $53.7M | Sell |
294,754
-2,279
| -0.8% | -$389K | 0.08% | 249 |
|
|
2016
Q3 | $48.7M | Buy |
297,033
+14,254
| +5% | +$2.16M | 0.07% | 259 |
|
|
2016
Q2 | $40.4M | Buy |
282,779
+761
| +0.3% | +$109K | 0.06% | 278 |
|
|
2016
Q1 | $38.5M | Buy |
282,018
+16,295
| +6% | +$2.14M | 0.03% | 297 |
|
|
2015
Q4 | $36.8K | Sell |
265,723
-2,896
| -1% | -$401K | 0.04% | 301 |
|
|
2015
Q3 | $36.1K | Buy |
268,619
+83,426
| +45% | +$12M | 0.04% | 311 |
|
|
2015
Q2 | $27.9K | Buy |
185,193
+5,829
| +3% | +$834K | 0.03% | 375 |
|
|
2015
Q1 | $24.2K | Sell |
179,364
-40,639
| -18% | -$5.04M | 0.03% | 395 |
|
|
2014
Q4 | $26.5K | Buy |
220,003
+134,905
| +159% | +$15.5M | 0.04% | 348 |
|
|
2014
Q3 | $9.65K | Sell |
85,098
-6,355
| -7% | -$753K | 0.01% | 641 |
|
|
2014
Q2 | $10.9M | Sell |
91,453
-14,895
| -14% | -$1.82M | 0.02% | 603 |
|
|
2014
Q1 | $13.6K | Buy |
106,348
+774
| +0.7% | +$99.2K | 0.02% | 551 |
|
|
2013
Q4 | $13.1K | Buy |
105,574
+3,745
| +4% | +$456K | 0.02% | 555 |
|
|
2013
Q3 | $12K | Buy |
101,829
+12,588
| +14% | +$1.48M | 0.02% | 559 |
|
|
2013
Q2 | $10M | Buy |
+89,241
| New | +$10.5M | 0.02% | 563 |
|
Other funds holding BIO
AI
Manulife (Manufacturers Life Insurance)'s BIO Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Bio-Rad Laboratories Class A (BIO) stake by 1.9% in Q2 2026, buying an estimated $528K and bringing the position to 101,580 shares worth $29.8M. The position accounts for 0.02% of the portfolio, ranked #538.
Manulife (Manufacturers Life Insurance) first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $60.8M in Q1 2017. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 101,580 shares of Bio-Rad Laboratories Class A worth $29.8M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 1,860 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $528K.
- Bio-Rad Laboratories Class A made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #538 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
- Manulife (Manufacturers Life Insurance)'s Bio-Rad Laboratories Class A position peaked at $60.8M in Q1 2017.
- 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.